After a recent trial, methylone no longer seems like a fringe compound and may be a future trauma therapeutic.

TSND-201 produced statistically significant placebo-adjusted improvements in PTSD severity.

The executive order dramatically affects research priorities, regulatory momentum, investment, and adoption.